News & Events


Important visitors at the CRC Hannover

Germany’s federal minister of research Karliczek and Lower Saxony’s minister Thümler came to update themselves on infection research in Lower Saxony.

read more

Innovative clinical study: a successful step in COPD research

February 22, 2018

Great success in COPD research: An innovative clinical study performed by Fraunhofer ITEM has shown the drug under investigation to improve not only lung function in COPD patients, but to have a significantly positive effect on their heart function as well. The study investigated a combination drug from Novartis Pharma AG (indacaterol/glycopyrronium) that has already been approved for COPD treatment. The results were published in the renowned journal "The Lancet Respiratory Medicine".

read more

Phase-I drug interaction study in Crohn’s disease patients initiated

February 2, 2018

In close collaboration with the Clinic for Gastroenterology, Hepatology and Endocrinology at the Hannover Medical School, the potential of ustekinumab to interfere with the pharmacokinetics of midazolam, warfarin, omeprazole, dextromethorphan, and caffeine is being explored at the CRC Hannover in a phase-I study with patients with moderate to severe Crohn's disease.

read more

New sleep laboratory: first study with a new antidepressant drug

January 25, 2018

Fraunhofer ITEM has extended the diagnostic possibilities in its clinical research by setting up a sleep laboratory with 4 beds in the phase-I unit of the Clinical Research Center Hannover.

read more


November 24, 2017

In a clinical study for method validation, performed in close collaboration with the Institute for Radiology of the Hannover Medical School, scientists were able to demonstrate that functional MRI with arterial spin labeling is a reliable method for quantification of kidney perfusion.

read more


Fourth Experts’ Forum on Pulmonary Fibrosis

Diagnosis and treatment of the different types of pulmonary fibrosis is a complex subject area that continues to evolve rapidly. Numerous studies on antifibrotic therapy in idiopathic pulmonary fibrosis (IPF) and also in the non-IPF types of pulmonary fibrosis were published and presented at international congresses in the past year. In addition, an update of the ATS/ERS guideline on the algorithm for diagnosing IPF has just been released. This update and the changes it implies will be the topic of the first lecture.

In the second lecture, Prof. Tobias Welte will present findings from the most recent influenza season.

Based on the proven scheme, we will then present you some interesting cases from the ILD Board of the Hannover Medical School and will be pleased to discuss with you the diagnostic findings and therapeutic implications.

go to event

ERS International Congress 2018

Respiratory professionals from all over the world will meet at this year’s congress of the European Respiratory Society. Fraunhofer ITEM scientists will be actively participating, presenting results of their recent airway research in a talk and several scientific posters.

go to event

ATS International Conference 2018

This year's annual conference of the American Thoracic Society (ATS) will be held from May 18 to 23 in San Diego, CA (USA). The American Thoracic Society improves global health by advancing research, patient care, and public health in pulmonary disease, critical illness, and sleep disorders.

go to event

DZL Annual Meeting 2018

From February 8 to 9, the German Center for Lung Research will hold its Annual Meeting 2018 in Bad Nauheim, Germany. Each year, scientists and junior researchers get together at this meeting to discuss a broad variety of topics related to lung diseases. For this year’s meeting, several Fraunhofer ITEM scientists have been selected to give oral presentations and to present their posters among the top ten posters in two disease areas.

go to event

17th Fraunhofer Seminar »Models of Lung Disease«

The 17th Fraunhofer Seminar "Models of Lung Disease" will be held in Hannover, Germany, on January 18 and 19, 2018.
Seating is limited - be sure not to miss this Event!

go to event